Marginal-Spalte zum Inhalt

Context Sensitive Search

Search all the listed ministerial websites with Google in one go (context sensitive list).


External Websites

Paul-Ehrlich Institute (PEI)

The Paul-Ehrlich-Institut is an institution of the Federal Republic of Germany. It reports to the Bundesministerium für Gesundheit (Federal Ministry of Health). Most of its activities relate to the various duties laid down in German and European medicinal product legislation, such as for example the approval of clinical trials and the marketing authorisation of particular groups of medicinal products. Since its foundation more than a hundred years ago the Paul-Ehrlich-Institut has concentrated on biological medicinal products: vaccines for humans and animals, medicinal products containing antibodies, allergens for therapy and diagnostics, blood and blood products and, more recently, tissue and medicinal products for gene therapy, somatic cell therapy and xenogenic cell therapy, i.e. for processes in the latest forms of biomedical treatment. These approval and marketing authorisation activities, together with the recording and assessment of undesirable effects (pharmacovigilance), are aimed at making medicinal products with a positive benefit/risk ratio available to the population.


Paul-Ehrlich Institute (PEI)
Paul-Ehrlich-Str. 51-53
63225 Langen


Phone: +49 6103 77 0


  • Research

Focus of Research:

  • host interactions with pathogens and retroelements
  • immunobiology of allergens
  • pathogen-induced immune activation and evasion
  • the safety and efficacy of biological medicinal products
  • viral gene transfer and cell therapy

Coordinated projects of subordinate institutions 4

Involved in research projects:

Subordinate Institutions: